Cargando…

Artificial intelligence predictive system of individual survival rate for lung adenocarcinoma

BACKGROUND: The current research aimed to develop an artificial intelligence predictive system for individual survival rate of lung adenocarcinoma (LUAD). METHODS: Independent risk variables were identified by multivariate Cox regression. Artificial intelligence predictive system was constructed usi...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Tingshan, Li, Jing, Wang, Peng, Zhang, Zhiqiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123088/
https://www.ncbi.nlm.nih.gov/pubmed/35615023
http://dx.doi.org/10.1016/j.csbj.2022.05.005
_version_ 1784711487415123968
author He, Tingshan
Li, Jing
Wang, Peng
Zhang, Zhiqiao
author_facet He, Tingshan
Li, Jing
Wang, Peng
Zhang, Zhiqiao
author_sort He, Tingshan
collection PubMed
description BACKGROUND: The current research aimed to develop an artificial intelligence predictive system for individual survival rate of lung adenocarcinoma (LUAD). METHODS: Independent risk variables were identified by multivariate Cox regression. Artificial intelligence predictive system was constructed using three different data mining algorithms. RESULTS: Stage, PM, chemotherapy, PN, age, PT, sex, and radiation_surgery were determined as risk factors for LUAD patients. For 12-month survival rate in model cohort, concordance indexes of RFS, MTLR, and Cox models were 0.852, 0.821, and 0.835, respectively. For 36-month survival rate in model cohort, concordance indexes of RFS, MTLR, and Cox models were 0.901, 0.864, and 0.862, respectively. For 60-month survival rate in model cohort, concordance indexes of RFS, MTLR, and Cox models were 0.899, 0.874, and 0.866, respectively. The concordance indexes in validation dataset were similar to those in model dataset. CONCLUSIONS: The current study designed an individualized survival predictive system, which could provide individual survival curves using three different artificial intelligence algorithms. This artificial intelligence predictive system could directly convey treatment benefits by comparing individual mortality risk curves under different treatments. This artificial intelligence predictive tool is available at https://zhangzhiqiao11.shinyapps.io/Artificial_Intelligence_Survival_Prediction_System_AI_E1001/.
format Online
Article
Text
id pubmed-9123088
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Research Network of Computational and Structural Biotechnology
record_format MEDLINE/PubMed
spelling pubmed-91230882022-05-24 Artificial intelligence predictive system of individual survival rate for lung adenocarcinoma He, Tingshan Li, Jing Wang, Peng Zhang, Zhiqiao Comput Struct Biotechnol J Research Article BACKGROUND: The current research aimed to develop an artificial intelligence predictive system for individual survival rate of lung adenocarcinoma (LUAD). METHODS: Independent risk variables were identified by multivariate Cox regression. Artificial intelligence predictive system was constructed using three different data mining algorithms. RESULTS: Stage, PM, chemotherapy, PN, age, PT, sex, and radiation_surgery were determined as risk factors for LUAD patients. For 12-month survival rate in model cohort, concordance indexes of RFS, MTLR, and Cox models were 0.852, 0.821, and 0.835, respectively. For 36-month survival rate in model cohort, concordance indexes of RFS, MTLR, and Cox models were 0.901, 0.864, and 0.862, respectively. For 60-month survival rate in model cohort, concordance indexes of RFS, MTLR, and Cox models were 0.899, 0.874, and 0.866, respectively. The concordance indexes in validation dataset were similar to those in model dataset. CONCLUSIONS: The current study designed an individualized survival predictive system, which could provide individual survival curves using three different artificial intelligence algorithms. This artificial intelligence predictive system could directly convey treatment benefits by comparing individual mortality risk curves under different treatments. This artificial intelligence predictive tool is available at https://zhangzhiqiao11.shinyapps.io/Artificial_Intelligence_Survival_Prediction_System_AI_E1001/. Research Network of Computational and Structural Biotechnology 2022-05-14 /pmc/articles/PMC9123088/ /pubmed/35615023 http://dx.doi.org/10.1016/j.csbj.2022.05.005 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Article
He, Tingshan
Li, Jing
Wang, Peng
Zhang, Zhiqiao
Artificial intelligence predictive system of individual survival rate for lung adenocarcinoma
title Artificial intelligence predictive system of individual survival rate for lung adenocarcinoma
title_full Artificial intelligence predictive system of individual survival rate for lung adenocarcinoma
title_fullStr Artificial intelligence predictive system of individual survival rate for lung adenocarcinoma
title_full_unstemmed Artificial intelligence predictive system of individual survival rate for lung adenocarcinoma
title_short Artificial intelligence predictive system of individual survival rate for lung adenocarcinoma
title_sort artificial intelligence predictive system of individual survival rate for lung adenocarcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123088/
https://www.ncbi.nlm.nih.gov/pubmed/35615023
http://dx.doi.org/10.1016/j.csbj.2022.05.005
work_keys_str_mv AT hetingshan artificialintelligencepredictivesystemofindividualsurvivalrateforlungadenocarcinoma
AT lijing artificialintelligencepredictivesystemofindividualsurvivalrateforlungadenocarcinoma
AT wangpeng artificialintelligencepredictivesystemofindividualsurvivalrateforlungadenocarcinoma
AT zhangzhiqiao artificialintelligencepredictivesystemofindividualsurvivalrateforlungadenocarcinoma